143 results on '"Sogni, P"'
Search Results
2. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)
3. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death
4. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)
5. C01/137 DETECTION OF HEPATITIS G VIRUS RNA IN A POPULATION OF FRENCH HAEMOPHILIACS
6. C16/244 RISK FACTORS ASSOCIATED WITH INTRAHEPATIC CHOLESTASIS OF PREGNANCY: AN UNI- AND MULTIVARIATE ANALYSIS.
7. Does HIV-infection influence the response of chronic hepatitis C to interferon treatment? A French multicenter prospective study
8. Hepatic and renal tolerance of immune checkpoint inhibitors for cancer treatment: A retrospective monocentric cohort study
9. Estimated glomerular filtration rate variations and direct acting antivirals treatment for chronic hepatitis C: a retrospective longitudinal study
10. Impact of elevated coffee intake on the risk of advanced liver fibrosis in HIV-HCV co-infected patients of the French ANRS CO13 HEPAVIH cohort: a sex-based analysis
11. The relationship between burn-associated cholangiopathy and outcome of critically ill burn adults
12. Protective effect of cannabis and coffee consumption on HCV-related mortality in French HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort)
13. FRI-512 - Hepatic and renal tolerance of immune checkpoint inhibitors for cancer treatment: A retrospective monocentric cohort study
14. THU-109 - Impact of elevated coffee intake on the risk of advanced liver fibrosis in HIV-HCV co-infected patients of the French ANRS CO13 HEPAVIH cohort: a sex-based analysis
15. THU-048 - Protective effect of cannabis and coffee consumption on HCV-related mortality in French HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort)
16. PS-079 - The relationship between burn-associated cholangiopathy and outcome of critically ill burn adults
17. PS-037 - Estimated glomerular filtration rate variations and direct acting antivirals treatment for chronic hepatitis C: a retrospective longitudinal study
18. Relationship between Alcohol use Disorders and Response to Antiviral Treatment on the Prognosis of Cirrhotic Patients with Chronic Hepatitis C
19. Retreatment of Sofosbuvir-Including Regimen Failures in the Real Life
20. The Relationship between FIB-4 Index Variations and Outcome in Patients with Chronic Hepatitis C and Cirrhosis: Comparison with Liver Stiffness Measurement
21. Non-Tumoral Portalvein Thrombosis and End-Stage Liver Disease in Patients with Cirrhosis: A Longitudinal Retrospective Cohort
22. P1266 : Human albumin use in cirrhotic patients in France: Results of the national “Albu-live” survey
23. LP20 : Safety and efficacy of all-oral daa regimens in HIV-HCV coinfected cirrhotic patients from the prospective ANRS CO13 - HEPAVIH cohort
24. P0326 : Hepatocellular carcinoma (HCC) in HCV-patients with or without HIV-coinfection. Similar survival in a nationwide study
25. FRI-208 - Retreatment of Sofosbuvir-Including Regimen Failures in the Real Life
26. THU-370 - Relationship between Alcohol use Disorders and Response to Antiviral Treatment on the Prognosis of Cirrhotic Patients with Chronic Hepatitis C
27. THU-341 - Non-Tumoral Portalvein Thrombosis and End-Stage Liver Disease in Patients with Cirrhosis: A Longitudinal Retrospective Cohort
28. 1205 PRELIMINARY EVALUATION OF A NEW AUTOPHAGY INHIBITOR ANTIVIRAL AGENT FOR HEPATITIS C VIRUS IN AN EX VIVO MODEL OF HUMAN LIVER SLICES CULTURE
29. 948 INCREASING INCIDENCE OF AUTOIMMUNE HEPATITIS
30. 1216 ACCESS TO HCV TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR WITH PEGINTERFERON RIBAVIRIN IN REAL LIFE SETTING IN HIV–HCV CO-INFECTED PATIENTS – ANRS CO13 Hepavih COHORT
31. 762 ADDITIONAL PEG-INTERFERON IN HBeAg-POSITIVE HIV CO-INFECTED PATIENTS ON cART INCLUDING TENOFOVIR: THE ANRS HB01 EMVIPEG STUDY
32. 914 INCIDENCE OF END STAGE LIVER DISEASE (ESLD) AND CAUSES OF DEATHS IN A COHORT OF HIV/HCV INFECTED PATIENTS IN FRANCE HEPAVIH ANRS C013’
33. 666 ROLE OF HEPATIC CYCLIC AMP IN THE RENAL DYSFUNCTION ASSOCIATED TO THE DEVELOPMENT OF ASCITES IN PATIENTS WITH CIRRHOSIS
34. 405 SUPERSONIC SHEAR IMAGING IS A NEW POTENT MORPHOLOGICAL NON-INVASIVE TECHNIQUE TO ASSESS OF LIVER FIBROSIS. PART II: COMPARISON WITH FIBROSCAN
35. 406 SUPERSONIC SHEAR IMAGING IS A NEW POTENT MORPHOLOGICAL NON-INVASIVE TECHNIQUE TO ASSESS LIVER FIBROSIS. PART I: TECHNICAL FEASABILITY
36. 1023 ADHERENCE TO ANTI-HBV ANALOGUES IN CLINICAL PRACTICE IS ASSOCIATED WITH VIROLOGICAL EFFICACY AND DEPENDS ON THE DURATION OF TREATMENTS AND THE PHYSICIAN'S EXPERIENCE
37. 1024 EFFICACY AND SAFETY OF THE COMBINATION OF ENTECAVIR (ETV)-TENOFOVIR (TDF) IN THE TREATMENT OF CHRONIC HEPATITIS B (CHB): A NATIONWIDE, RETROSPECTIVE STUDY
38. 421 IS LIVER STIFFNESS ACCURATE TO DEFINE REGRESSION OF CIRRHOSIS IN PATIENTS CURED FROM CHRONIC HEPATITIS C?
39. 841 EFFICACY AND SAFETY OF 2 YEARS MAINTENANCE THERAPY WITH PEGINTERFERON ALPHA-2A IN CHRONIC HEPATITIS C: RESULTS OF A RANDOMIZED CONTROLLED TRIAL (FIBROSYS)
40. Association between aortic eNOS overactivation and enhanced shear stress in rats with cirrhosis
41. Helicobacter pylori infection after liver transplantation
42. Prospective study of the correlation between the development of liver fibrosis and hemodynamic changes in patients with HCV infection
43. Effect of a non-steroidal anti-inflammatory drug (NSAID)-no donor (NO) on LPS-induced vascular hyporeactivity and expression of inducible no synthase (NOS II) in cirrhotic rats
44. Renal oxygen consumption in patients with cirrhosis
45. Hemodynamic changes in conscious portal vein stenosed rats with portal hypertension. Influence of the diameter and the duration of stenosis
46. Amino acids (AA) infusion induces renal hyperemia but not hyperfiltration in patients with cirrhosis
47. Deleterious systemic hemodynamic effects of vasopressin in portal hypertensive rats receiving propranolol
48. Relationships between plasma atrial natriuretic peptide (ANP) and hematocrit, pulmonary artery and portal pressures in patients with cirrhosis
49. Effects of lipopolysaccharide on TNF-alpha production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis
50. The role of nitric oxide in the reduction of protein kinase C-induced contractile response in aortae from rats with portal hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.